ParcelBio
Pre-clinicalParcelBio develops AI-powered drug discovery platforms to accelerate the identification of novel therapeutics.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $30M
About
ParcelBio develops AI-powered drug discovery platforms to accelerate the identification of novel therapeutics.
RNA & Gene Therapy
Funding History
2Total raised:$30M
Series A$25MNov 15, 2023
Seed$5MJun 15, 2022